US Patent Issued to Nordic Bioscience on Feb. 24 for "Neo-epitope specific assay measuring protease mediated degradation of type IV collagen" (Danish Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,543, issued on Feb. 24, was assigned to Nordic Bioscience A/S (Herlev, Denmark).

"Neo-epitope specific assay measuring protease mediated degradation of type IV collagen" was invented by Nicholas Willumsen (Dyssegard, Denmark), Christine Jensen (Kobenhavn N, Denmark) and Morten A. Karsdal (Kobenhavn O, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "An assay measuring protease mediated degradation of type IV collagen and its biomarker potential for identifying cancer patients with a T-cell permissive tumor microenvironment is described."

The patent was filed on Dec. 3, 2020, under Application No. 17/782,468.

*For further information, includi...